Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07754474
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07754474Not Yet Recruiting
Phase 1
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerate...Boehringer Ingelheim
NCT07755488
Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteotomy for Hallux Valgus: a Prospective Study Using Surface 3D ScanningGroupe Hospitalier Diaconesses Croix Saint-SimonNot Yet RecruitingNot Applicable
NCT07755488Not Yet Recruiting
Not Applicable
Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteo...Groupe Hospitalier Diacon...
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07754318
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic CardiovascularNot Yet RecruitingNot Applicable
NCT07754318Not Yet Recruiting
Not Applicable
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic Cardiovascular
NCT07754682
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07754682Not Yet Recruiting
Phase 3
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in...Assistance Publique - Hôp...
NCT07754773
Motus Nova Foot Device for Patients With HemiplegiaMultiCare Health System Research InstituteNot Yet RecruitingNot Applicable
NCT07754773Not Yet Recruiting
Not Applicable
Motus Nova Foot Device for Patients With HemiplegiaMultiCare Health System R...
NCT07754890
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical College HospitalRecruitingPhase 1
NCT07754890Recruiting
Phase 1
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical Coll...
NCT07756580
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar LinesAbbVieNot Yet RecruitingPhase 1
NCT07756580Not Yet Recruiting
Phase 1
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Follow...AbbVie
NCT07755579
Effect of Autologous Ear Cartilage Micrografting in Knee OsteoarthritisOrthosera Kft.Active Not RecruitingNot Applicable
NCT07755579Active Not Recruiting
Not Applicable
Effect of Autologous Ear Cartilage Micrografting in Knee OsteoarthritisOrthosera Kft.
NCT07754331
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinAstraZenecaNot Yet RecruitingPhase 1
NCT07754331Not Yet Recruiting
Phase 1
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolera...AstraZeneca
NCT07756606
Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools on ChildrenCenters for Disease Control and PreventionNot Yet RecruitingNot Applicable
NCT07756606Not Yet Recruiting
Not Applicable
Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools...Centers for Disease Contr...
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07754994
Medication Self-Management Technology for Older AdultsArizona State UniversityNot Yet RecruitingNot Applicable
NCT07754994Not Yet Recruiting
Not Applicable
Medication Self-Management Technology for Older AdultsArizona State University
NCT07754526
OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care Treatment Alone.Omeza, LLCNot Yet RecruitingNot Applicable
NCT07754526Not Yet Recruiting
Not Applicable
OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care T...Omeza, LLC
NCT07754838
Acoustic Stimulation to Study and Modulate Sleepwalking and Related Arousal DisordersAnna CastelnovoNot Yet RecruitingNot Applicable
NCT07754838Not Yet Recruiting
Not Applicable
Acoustic Stimulation to Study and Modulate Sleepwalking and Related Arousal Diso...Anna Castelnovo
NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerRevolution Medicines, Inc.Not Yet RecruitingPhase 1
NCT07756281Not Yet Recruiting
Phase 1
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pa...Revolution Medicines, Inc...
NCT07754877
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter StudyPeking University Aerospace Center HospitalNot Yet RecruitingNot Applicable
NCT07754877Not Yet Recruiting
Not Applicable
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combin...Peking University Aerospa...
NCT07754721
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health ImpactsHualien Tzu Chi General HospitalRecruitingNot Applicable
NCT07754721Recruiting
Not Applicable
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study...Hualien Tzu Chi General H...
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Active, not recruiting1 (5%)
not_applicable12 (60%)
Phase 15 (25%)
Phase 31 (5%)
Phase 41 (5%)
Not Specified1 (5%)